Cheng J - Search Results

1

T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape.

Dai Z, Mu W, Zhao Y, Cheng J, Lin H, Ouyang K, Jia X, Liu J, Wei Q, Wang M, Liu C, Tan T, Zhou J. Dai Z, et al. Among authors: cheng j. Signal Transduct Target Ther. 2022 Mar 25;7(1):85. doi: 10.1038/s41392-022-00898-z. Signal Transduct Target Ther. 2022. PMID: 35332132 Free PMC article.

2

The unique role of the hepatitis virus B X protein on HEK 293 cell morphology and cellular change.

Zhang Y, Cheng J, Liu C. Zhang Y, et al. Among authors: cheng j. Arch Virol. 2016 May;161(5):1347-52. doi: 10.1007/s00705-016-2786-y. Epub 2016 Feb 12. Arch Virol. 2016. PMID: 26873814

3

The Coordination Between B Cell Receptor Signaling and the Actin Cytoskeleton During B Cell Activation.

Li J, Yin W, Jing Y, Kang D, Yang L, Cheng J, Yu Z, Peng Z, Li X, Wen Y, Sun X, Ren B, Liu C. Li J, et al. Among authors: cheng j. Front Immunol. 2019 Jan 9;9:3096. doi: 10.3389/fimmu.2018.03096. eCollection 2018. Front Immunol. 2019. PMID: 30687315 Free PMC article. Review.

4

Determination of Epstein-Barr Virus-Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases.

Zhang P, Zeng C, Cheng J, Zhou J, Gu J, Mao X, Zhang W, Cao Y, Luo H, Xu B, Li Q, Xiao M, Zhou J. Zhang P, et al. Among authors: cheng j. Open Forum Infect Dis. 2019 Apr 4;6(5):ofz171. doi: 10.1093/ofid/ofz171. eCollection 2019 May. Open Forum Infect Dis. 2019. PMID: 31065564 Free PMC article.

5

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies.

Wang N, Hu X, Cao W, Li C, Xiao Y, Cao Y, Gu C, Zhang S, Chen L, Cheng J, Wang G, Zhou X, Zheng M, Mao X, Jiang L, Wang D, Wang Q, Lou Y, Cai H, Yan D, Zhang Y, Zhang T, Zhou J, Huang L. Wang N, et al. Among authors: cheng j. Blood. 2020 Jan 2;135(1):17-27. doi: 10.1182/blood.2019000017. Blood. 2020. PMID: 31697824 Free article. Clinical Trial.

6

Understanding the Mechanisms of Resistance to CAR T-Cell Therapy in Malignancies.

Cheng J, Zhao L, Zhang Y, Qin Y, Guan Y, Zhang T, Liu C, Zhou J. Cheng J, et al. Front Oncol. 2019 Nov 21;9:1237. doi: 10.3389/fonc.2019.01237. eCollection 2019. Front Oncol. 2019. PMID: 31824840 Free PMC article. Review.

7

Efficacy and toxicity for CD22/CD19 chimeric antigen receptor T-cell therapy in patients with relapsed/refractory aggressive B-cell lymphoma involving the gastrointestinal tract.

Zeng C, Cheng J, Li T, Huang J, Li C, Jiang L, Wang J, Chen L, Mao X, Zhu L, Lou Y, Zhou J, Zhou X. Zeng C, et al. Among authors: cheng j. Cytotherapy. 2020 Mar;22(3):166-171. doi: 10.1016/j.jcyt.2020.01.008. Epub 2020 Feb 13. Cytotherapy. 2020. PMID: 32063474

8

The role of ubiquitinase in B cell development and function.

Zhang T, Sun J, Cheng J, Yin W, Li J, Miller H, Herrada AA, Gu H, Song H, Chen Y, Gong Q, Liu C. Zhang T, et al. Among authors: cheng j. J Leukoc Biol. 2021 Feb;109(2):395-405. doi: 10.1002/JLB.1MR0720-185RR. Epub 2020 Aug 20. J Leukoc Biol. 2021. PMID: 32816356 Review.

9

Fueling chimeric antigen receptor T cells with cytokines.

Jin J, Cheng J, Huang M, Luo H, Zhou J. Jin J, et al. Among authors: cheng j. Am J Cancer Res. 2020 Dec 1;10(12):4038-4055. eCollection 2020. Am J Cancer Res. 2020. PMID: 33414984 Free PMC article. Review.

10

Advances in Universal CAR-T Cell Therapy.

Lin H, Cheng J, Mu W, Zhou J, Zhu L. Lin H, et al. Among authors: cheng j. Front Immunol. 2021 Oct 6;12:744823. doi: 10.3389/fimmu.2021.744823. eCollection 2021. Front Immunol. 2021. PMID: 34691052 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21,274 results

Search Page